Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06346067
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-03-17
Brief Title:
A Study to Assess Naporafenib ERAS-254 Administered With Trametinib in Patients With NRAS-mutant Melanoma SEACRAFT-2
Sponsor:
Erasca Inc
Organization:
Erasca Inc